North Idaho Cancer Center — Coeur d'Alene, Idaho

North Idaho Cancer Center is a clinical research site located in Coeur d'Alene, Idaho, United States 83814.

Crixeo Clinical Trials Trust Score: 21/100 (FAILING). This profile has not yet been claimed by the site owner.

North Idaho Cancer Center has participated in 20 clinical trials.

Therapeutic areas: Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer.

Sponsors: Genentech, Inc., Accelerated Community Oncology Research Network, NSABP Foundation Inc.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Coeur d'Alene

Browse all research sites in Idaho · View every site in Coeur d'Alene

• Northwest Specialty Hospital
• Kootenai Hospital District dba Kootenai Health
• University of Idaho
• Kootenai Health - Coeur d'Alene
• Kootenai Medical Center
• GSK Investigational Site
• Research Site
• North Idaho Urology
• Coeur D'Alene Arthritis Clinic
• Kootenai Health
• Novartis Investigative Site

Sponsor Feasibility Report

Trust Score: 21/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for North Idaho Cancer Center?

North Idaho Cancer Center has a Crixeo Trust Score of 21/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has North Idaho Cancer Center conducted?

North Idaho Cancer Center has 20 clinical trials on record. Their work covers Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer.

Is North Idaho Cancer Center accredited by Crixeo Clinical Trials?

North Idaho Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about North Idaho Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.